secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2023-04-28T23:59:59+00:00
Accession:  0001193125-23-123358
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical shareholders approve share issuance for NuVasive merger; 99.92% vote in favor
--------------------------------------------------------------------------------

- 99.92% of votes cast approved share issuance; 99.66% of Class A and 100% of Class B voted for.
- Exchange ratio: 0.75 Globus Class A shares for each NuVasive share; NuVasive holders to own ~28% of combined co.
- Combined company will have over 5,000 employees focused on musculoskeletal solutions and enabling technologies.
- Merger expected to close after regulatory clearance and satisfaction of other customary conditions.
- Globus Medical to report Q1 2023 earnings on May 4, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000119312523123358/0001193125-23-123358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000119312523123358/d469616d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-123358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer